| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 11.630 | 42.895 | 66.417 | 69.386 | 87.871 | 117.592 | 158.407 | 184.272 |
| Total Income - EUR | - | - | 11.630 | 42.910 | 66.423 | 69.394 | 88.599 | 117.593 | 158.408 | 184.420 |
| Total Expenses - EUR | - | - | 12.227 | 25.376 | 42.521 | 41.243 | 55.056 | 71.006 | 81.764 | 125.538 |
| Gross Profit/Loss - EUR | - | - | -597 | 17.534 | 23.903 | 28.151 | 33.543 | 46.586 | 76.644 | 58.882 |
| Net Profit/Loss - EUR | - | - | -713 | 17.105 | 23.238 | 27.491 | 32.657 | 45.434 | 75.091 | 53.536 |
| Employees | - | - | 1 | 2 | 2 | 2 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Chelaru Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 13.969 | 16.209 | 16.254 | 17.553 | 16.999 | 23.394 |
| Current Assets | - | - | 5.341 | 21.144 | 22.784 | 31.738 | 24.989 | 32.551 | 67.701 | 42.020 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 1.914 | 0 | 6.527 | 0 | 9.519 | 32.138 | 64.698 | 32.302 |
| Cash | - | - | 3.427 | 21.144 | 16.256 | 31.738 | 15.470 | 413 | 3.003 | 9.719 |
| Shareholders Funds | - | - | -669 | 16.448 | 34.525 | 44.605 | 37.611 | 45.483 | 75.140 | 53.585 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 6.010 | 4.696 | 2.227 | 3.341 | 3.631 | 4.621 | 9.560 | 11.830 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Chelaru Med Srl